VASP and gastric cancer: In conclusion, our data demonstrate that miR-4455 suppresses tumorigenesis in GC cells in vitro, by directly targeting VASP in GC cells, finally leading to the inhibition of VASP mediated proliferation, migration and invasion of gastric cancer cells.